Nickel contamination on MWCNT is related to particle bioactivity but not toxicity in the THP-1 transformed macrophage model
by Raymond F. Hamilton Jr.; Teri A. Girtsman; Chengcheng Xiang; Nianqiang Wu; Andrij Holian
International Journal of Biomedical Nanoscience and Nanotechnology (IJBNN), Vol. 3, No. 1/2, 2013

Abstract: The potential pathogenic effects from exposure to various MWCNT have not been adequately determined. One potential contributing factor to MWCNT bioactivity could be metal contamination that occurs during production. This study examined the toxicity and bioactivity (NLRP3 inflammasome activation), of 24 commercially available MWCNT in a macrophage-like differentiated THP-1 cell line. Inflammasome activation, via IL-1β release, was highly correlated to Ni content. Soluble NiCl₂ and insoluble Ni nanopowder were tested in the same model at varying concentrations with no inflammasome activation. Ni-decorated MWCNT were also tested in the THP-1 model and the results also correlated with Ni content. These results demonstrated that Ni content correlated to NLRP3 inflammasome activation, but not toxicity. Taken together, the results suggest that Ni, when fixed to MWCNT, is highly bioactive and potentially proinflammatory. The related mechanism probably involves lysosomal rupture, release of cathepsin B, and NLRP3 activation.

Online publication date: Sat, 12-Jul-2014

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biomedical Nanoscience and Nanotechnology (IJBNN):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com